Home›Companies›Biotech & Pharma›Amydis

Amydis, Inc.

Updated Oct 29, 2026·Latest SEC filing Dec 28, 2023·Suggest an edit

About Amydis

Amydis is a private company based in Los Angeles, California. It has reported $14,685,723 raised in three offerings on Form D since April 2022. Its chief executive is Stella Sarraf.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 14, 2023Dec 28, 2023$3,000,000of $6.0M target1$3.0MDebt, Options, Securities on exercise, Offering of convertible promissory notes and the underlying equity securities issuable upon such conversion.Rule 506(b)Form D ↗
Dec 20, 2022Dec 29, 2022$5,999,991of $9.0M target2$2.9MEquityRule 506(b)Form D ↗
Feb 16, 2022Apr 22, 2022$5,685,732fully sold14$406KEquityRule 506(b)Form D ↗
Total, three offerings$14,685,723

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Amydis's Form D filed Dec 28, 2023.

MT
Mervyn Turner
Director
Also a director at Spinogenix.
SS
Stella Sarraf
CEO and director
Also an executive officer and director at Spinogenix.
Jerre Stead
Jerre Stead
Director
Also a director at Spinogenix.
JC
Jack Thrift, CPA
Executive officer

Earlier filings also listed Faith Charles (director, last listed Apr 2022).

Sources

  1. SECAmydis, Inc. filing history